Goldman Sachs’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-30,960	Closed	-$38K	–	5883
2018 Q3	$38K	Sell	30,960 -6,542	-17%	-$7.31K	﹤0.01%	5334
2018 Q2	$42K	Sell	37,502 -149	-0.4%	-$226	﹤0.01%	5400
2018 Q1	$76K	Sell	37,651 -10,203	-21%	-$19.2K	﹤0.01%	5368
2017 Q4	$57K	Sell	47,854 -40,564	-46%	-$55.4K	﹤0.01%	5916
2017 Q3	$111K	Sell	88,418 -305,309	-78%	-$390K	﹤0.01%	6019
2017 Q2	$524K	Buy	393,727 +181,042	+85%	+$262K	﹤0.01%	5059
2017 Q1	$396K	Buy	212,685 +194,507	+1,070%	+$880K	﹤0.01%	5231
2016 Q4	$94K	Sell	18,178 -5,155	-22%	-$27.1K	﹤0.01%	6172
2016 Q3	$130K	Buy	23,333 +6,641	+40%	+$37.9K	﹤0.01%	6093
2016 Q2	$93K	Buy	16,692 +1,674	+11%	+$8.79K	﹤0.01%	6165
2016 Q1	$66K	Buy	15,018 +1,786	+13%	+$7.35K	﹤0.01%	6289
2015 Q4	$80K	Sell	13,232 -709	-5%	-$4.81K	﹤0.01%	6297
2015 Q3	$109K	Buy	+13,941	New	+$108K	﹤0.01%	6431
2015 Q2	–	Sell	-21,862	Closed	-$176K	–	7541
2015 Q1	$176K	Buy	+21,862	New	+$165K	﹤0.01%	6110